v3.24.1.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating activities:    
Net loss $ (11,505) $ (22,617)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 1,252 1,466
Reduction in the carrying amount of right-of-use assets 773 1,249
Stock-based compensation 3,171 2,809
Equity securities earned from research and development activities 0 (50)
Non-cash interest expense 82 0
Amortization of discount on short-term investments (41) 0
Other non-cash items (10) (5)
Changes in operating assets and liabilities:    
Financial assets 5,571 20,856
Inventories 244 33
Prepaid expenses and other assets (146) 586
Accounts payable (2,038) 694
Accrued compensation and other accrued liabilities (3,875) (11,091)
Other long-term liabilities (996) (1,415)
Deferred revenue (271) (1,727)
Net cash used in operating activities (7,789) (9,212)
Investing activities:    
Purchase of property and equipment (1,130) (2,539)
Proceeds from sale of property and equipment 11 5
Investment in short-term investments 27,444 0
Investment in non-marketable securities 0 (750)
Net cash used in investing activities (28,563) (3,284)
Financing activities:    
Proceeds from exercises of stock options 281 281
Proceeds from issuance of common stock in connection with public offering 0 1,540
Costs incurred in connection with issuance of common stock at public offering (60) (65)
Proceeds from long-term debt 29,521 0
Payment of debt issuance costs (461) 0
Taxes paid related to net share settlement of equity awards 0 (404)
Net cash provided by financing activities 29,281 1,352
Net decrease in cash, cash equivalents and restricted cash (7,071) (11,144)
Cash, cash equivalents and restricted cash at the beginning of the period 66,697 116,026
Cash, cash equivalents and restricted cash at the end of the period 59,626 104,882
Supplemental disclosure of cash flow information:    
Interest paid 147 7
Income taxes paid 17 193
Supplemental non-cash investing and financing activities:    
Capital expenditures incurred but not yet paid 371 819
Cash reconciliation:    
Cash and cash equivalents 58,046 102,831
Restricted cash, current and non-current 1,580 2,051
Total cash, cash equivalents and restricted cash $ 59,626 $ 104,882

Source

PDF HTML 10-Q Filing
ZIP XBRL